Cervical cancer incidence higher in states with lower proportion of HPV vaccination rates
the ONA take:
According to new findings presented at the American Association for Cancer Research (AACR) conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved in San Antonio, Texas, researchers from the University of North Carolina Gillings School of Global Public Health in Chapel Hill, North Carolina, the number of adolescent girls receiving the human papillomavirus (HPV) vaccine is much lower in states with higher rates of cervical cancer and cervical cancer-related mortality.
Using the National Immunization Survey-Teen, researchers identified the rates of HPV vaccination in various states, and identified cervical cancer rates in the same states using the United States Cancer Statistics database. States with higher vaccination rates had lower cancer incidence rates and vice versa.
For example, in Massachusetts, 69% of adolescent girls have begun the HPV vaccination series and 6 per 100,000 women develop cervical cancer a year, whereas in Arkansas, 41% of adolescent girls have initiated HPV vaccination and 10 per 100,000 women develop cervical cancer a year. In addition, completion rates of the HPV vaccine course were higher in states where adolescents have higher levels of contact with the healthcare system.
The researchers suggest that more adolescent preventive health care may be needed to improve completion rates of the HPV vaccination series.
Number of adolescent girls receiving the HPV vaccine much lower in states with higher rates of cervical cancer.
The proportion of adolescent girls receiving human papillomavirus (HPV) vaccines was much lower in states with higher rates of cervical cancer incidence and mortality, according to data presented at the American Association for Cancer Research (AACR) conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 9–12.
HPV vaccines can prevent individuals from developing several types of cancer, including cervical, anal, vaginal, and vulvar cancers. "Cervical cancer incidence and mortality rates vary widely by state," said Jennifer L. Moss, MSPH, a doctoral student in the Department of Health Behavior at the University of North Carolina Gillings School of Global Public Health in Chapel Hill.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|